102 related articles for article (PubMed ID: 9279349)
1. [Efficacy of combination chemotherapy of cyclophosphamide and 5'-deoxy-5-fluorouridine in a mammary tumor xenograft model, MX-1].
Endo M; Fujimoto-Ouchi K; Matsumoto T; Tanaka Y; Ishitsuka H
Gan To Kagaku Ryoho; 1997 Aug; 24(10):1295-301. PubMed ID: 9279349
[TBL] [Abstract][Full Text] [Related]
2. Induction of thymidine phosphorylase expression and enhancement of efficacy of capecitabine or 5'-deoxy-5-fluorouridine by cyclophosphamide in mammary tumor models.
Endo M; Shinbori N; Fukase Y; Sawada N; Ishikawa T; Ishitsuka H; Tanaka Y
Int J Cancer; 1999 Sep; 83(1):127-34. PubMed ID: 10449619
[TBL] [Abstract][Full Text] [Related]
3. The efficacy of long-term oral chemotherapy with 5'-deoxy-5-fluorouridine and cyclophosphamide for recurrent breast cancer.
Iba T; Kidokoro A; Fukunaga M; Sugiyama K; Aihara N; Suda M
Int J Clin Oncol; 2004 Oct; 9(5):383-7. PubMed ID: 15549589
[TBL] [Abstract][Full Text] [Related]
4. Schedule dependency of antitumor activity in combination therapy with capecitabine/5'-deoxy-5-fluorouridine and docetaxel in breast cancer models.
Fujimoto-Ouchi K; Tanaka Y; Tominaga T
Clin Cancer Res; 2001 Apr; 7(4):1079-86. PubMed ID: 11309360
[TBL] [Abstract][Full Text] [Related]
5. [Combination chemotherapy with 3 or 4 drugs on human breast and gastrointestinal cancer xenografts in nude mice (II)].
Fujita F; Fujita M; Sakamoto Y; Shimozuma K; Inaba H; Taguchi T
Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 1):1252-9. PubMed ID: 2953310
[TBL] [Abstract][Full Text] [Related]
6. [Effects of alternating chemotherapy with 2 non-cross-resistant drug combinations on human alimentary and breast cancer xenografts in nude mice].
Fujita F; Fujita M; Yamauchi T; Sakamoto Y; Shimozuma K; Inaba H; Taguchi T
Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 1):1297-304. PubMed ID: 2953311
[TBL] [Abstract][Full Text] [Related]
7. Antitumor efficacy of combination chemotherapy with UFT and cyclophosphamide against human breast cancer xenografts in nude mice.
Haga S; Shimizu T; Imamura H; Watanabe O; Kinoshita J; Fukushima M; Kajiwara T
Anticancer Res; 1999; 19(3A):1791-6. PubMed ID: 10470117
[TBL] [Abstract][Full Text] [Related]
8. Clinical usefulness of oral combination chemotherapy of 5'-deoxy-5-fluorouridine (5'-DFUR) and cyclophosphamide for metastatic breast cancer.
Yamashita T; Yamashita H; Itoh Y; Karamatsu S; Itoh K; Hara Y; Ando Y; Sugiura H; Kuzushima T; Toyama T; Iwata H; Kobayashi S; Iwase H
Breast Cancer; 2006; 13(4):334-9. PubMed ID: 17146158
[TBL] [Abstract][Full Text] [Related]
9. Preferential inhibition of bone metastases by 5'-deoxy-5-fluorouridine and capecitabine in the 4T1/luc mouse breast cancer model.
Hiraga T; Hata K; Ikeda F; Kitagaki J; Fujimoto-Ouchi K; Tanaka Y; Yoneda T
Oncol Rep; 2005 Sep; 14(3):695-9. PubMed ID: 16077977
[TBL] [Abstract][Full Text] [Related]
10. [The efficacy of combination chemotherapy of 5'-deoxy-5-fluorouridine (5'-DFUR), cyclophosphamide (CPA) and medroxyprogesterone acetate (MPA) for bone metastasis in breast cancer patients].
Iba T; Kidokoro A; Fukunaga M; Sugiyama K; Aihara N; Suda M
Gan To Kagaku Ryoho; 2001 Jul; 28(7):973-7. PubMed ID: 11478147
[TBL] [Abstract][Full Text] [Related]
11. [Successful treatment of disseminated breast cancer with combination therapy of 5'-deoxy-5'-fluorouridine (5'-DFUR), medroxyprogesterone acetate (MPA) and cyclophosphamide (CPA)].
Takatsuka Y; Katoh T; Tsumura I; Kobayakawa K; Kawahara T
Gan To Kagaku Ryoho; 1992 Jan; 19(1):107-10. PubMed ID: 1530905
[TBL] [Abstract][Full Text] [Related]
12. Antitumor effect and metabolic activation of cyclophosphamide and 4-hydroperoxycyclophosphamide in the human breast carcinoma (MX-1)-nude mouse system.
Kubota T; Hanatani Y; Tsuyuki K; Nakada M; Ishibiki K; Abe O; Kamataki T; Kato R
Gan; 1983 Jun; 74(3):437-44. PubMed ID: 6884701
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of antitumor activity of 5'-deoxy-5-fluorouridine (Furtulon) by taxane in human gastric cancer xenografts.
Sawada N; Nose T; Ishikawa T; Yutaka T
Oncol Rep; 2005 Jul; 14(1):53-7. PubMed ID: 15944767
[TBL] [Abstract][Full Text] [Related]
14. Combination chemotherapy with a new folate analog: activity of 10-ethyl-10-deaza-aminopterin compared to methotrexate with 5-fluorouracil and alkylating agents against advanced metastatic disease in murine tumor models.
Schmid FA; Sirotnak FM; Otter GM; DeGraw JI
Cancer Treat Rep; 1987; 71(7-8):727-32. PubMed ID: 3607784
[TBL] [Abstract][Full Text] [Related]
15. A case of metastatic breast cancer achieving complete response by combination therapy with 5'-deoxy-5-fluorouridine and cyclophosphamide.
Iwata H; Mizutani M; Iwase T; Murai H; Miura S
Breast Cancer; 2000 Jan; 7(1):83-6. PubMed ID: 11029777
[TBL] [Abstract][Full Text] [Related]
16. Signal therapy of human pancreatic cancer and NF1-deficient breast cancer xenograft in mice by a combination of PP1 and GL-2003, anti-PAK1 drugs (Tyr-kinase inhibitors).
Hirokawa Y; Levitzki A; Lessene G; Baell J; Xiao Y; Zhu H; Maruta H
Cancer Lett; 2007 Jan; 245(1-2):242-51. PubMed ID: 16540233
[TBL] [Abstract][Full Text] [Related]
17. [A case of breast cancer with lung and bone metastasis treated successfully by oral combination chemotherapy of 5'-deoxy-5-fluorouridine and cyclophosphamide].
Ishii K; Tsugawa K; Nakamura M; Ohnishi I; Miwa K
Gan To Kagaku Ryoho; 2003 Dec; 30(13):2133-6. PubMed ID: 14712778
[TBL] [Abstract][Full Text] [Related]
18. Combination of N,N',N"-triethylenethiophosphoramide and cyclophosphamide in vitro and in vivo.
Teicher BA; Holden SA; Cucchi CA; Cathcart KN; Korbut TT; Flatow JL; Frei E
Cancer Res; 1988 Jan; 48(1):94-100. PubMed ID: 3121169
[TBL] [Abstract][Full Text] [Related]
19. Antitumor activity of menogaril alone, and in combination against human mammary cancer models in mice and rats.
Yoshida M; Fujioka A; Nakano K; Kobunai T; Saito H; Toko T; Takeda S; Unemi N
Anticancer Res; 1996; 16(3A):1155-9. PubMed ID: 8702227
[TBL] [Abstract][Full Text] [Related]
20. [Augmentation of chemotherapeutic efficaciousness of UFT by oral l-leucovorin--growth-inhibitory activity of combination against human tumor xenograft].
Saito H; Okabe H; Nakano K; Fujioka A; Toko T; Takeda S; Unemi N
Gan To Kagaku Ryoho; 1995 Nov; 22(13):1919-25. PubMed ID: 7487121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
